Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis

被引:36
作者
Adegbola, O [1 ]
Pasternack, GR [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Mol Pathol, Baltimore, MD 21205 USA
关键词
D O I
10.1074/jbc.M411382200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoblastoma gene product (Rb) is a tumor suppressor that affects apoptosis paradoxically. Most sporadic cancers inactivate Rb by preferentially targeting the pathway that regulates Rb phosphorylation, resulting in resistance to apoptosis; this contrasts with Rb inactivation by mutation, which is associated with high rates of apoptosis. How phosphorylated Rb protects cells from apoptosis is not well understood, but there is evidence that Rb may sequester a pro-apoptotic nuclear factor. pp32 (ANP32A) is a pro-apoptotic nuclear phosphoprotein, the expression of which is commonly increased in cancer. We report that hyperphosphorylated Rb interacts with pp32 but not with the closely related proteins pp32r1 and pp32r2. We further demonstrate that pp32-Rb interaction inhibits the apoptotic activity of pp32 and stimulates proliferation. These results suggest a mechanism whereby cancer cells gain both a proliferative and survival advantage when Rb is inactivated by hyperphosphorylation.
引用
收藏
页码:15497 / 15502
页数:6
相关论文
共 46 条
  • [1] DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS
    ALMASAN, A
    YIN, YX
    KELLY, RE
    LEE, EYHP
    BRADLEY, A
    LI, WW
    BERTINO, JR
    WAHL, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5436 - 5440
  • [2] Tumor suppression and potentiation by manipulation of pp32 expression
    Bai, JN
    Brody, JR
    Kadkol, SHS
    Pasternack, GR
    [J]. ONCOGENE, 2001, 20 (17) : 2153 - 2160
  • [3] Constitutively active protein phosphatase 1 alpha causes Rb-dependent G1 arrest in human cancer cells
    Berndt, N
    Dohadwala, M
    Liu, CWY
    [J]. CURRENT BIOLOGY, 1997, 7 (06) : 375 - 386
  • [4] Berry DE, 1996, ONCOGENE, V12, P1809
  • [5] Protein ligands to HuR modulate its interaction with target mRNAs in vivo
    Brennan, CM
    Gallouzi, IE
    Steitz, JA
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 151 (01) : 1 - 13
  • [6] Identification of sequences required for inhibition of oncogene-mediated transformation by pp32
    Brody, JR
    Kadkol, SS
    Mahmoud, MA
    Rebel, JMJ
    Pasternack, GR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) : 20053 - 20055
  • [7] pp32 reduction induces differentiation of TSU-Pr1 cells
    Brody, JR
    Kadkol, SS
    Hauer, MC
    Rajaii, F
    Lee, J
    Pasternack, GR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) : 273 - 283
  • [8] Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb
    Chau, BN
    Borges, HL
    Chen, TT
    Masselli, A
    Hunton, IC
    Wang, YJY
    [J]. NATURE CELL BIOLOGY, 2002, 4 (10) : 757 - 765
  • [9] Coordinated regulation of life and death by RB
    Chau, BN
    Wang, JYJ
    [J]. NATURE REVIEWS CANCER, 2003, 3 (02) : 130 - 138
  • [10] Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci
    Chen, TH
    Brody, JR
    Romantsev, RE
    Yu, JG
    Kayler, AE
    Voneiff, E
    Kuhajda, FP
    Pasternack, GR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (12) : 2045 - 2056